Endomimetics

We created Bionanomatrix™ a peptide-based nanomaterial which promotes healing & improves outcomes following med device implantation & other procedures. We develop apps for the Bionanomatrix™ then partner with med device companies whose tech could benefit bit.ly/3zzICt9

Read more about our latest asset on our new Wefunder page! wefunder.com/endomimetics.in…

A structured approach to biotech investing: scalable platform upside, with individual assets advancing toward clearly defined outcomes and exits. Learn more > endomimetics.com/investors/

Coronary stents enhanced with Bionanomatrix™ promote improved vessel recovery, reducing the risks of thrombosis and restenosis. Read more on our pipeline > endomimetics.com/pipeline/

Innovation that drives impact.  Endomimetics® is shaping the future of healing with Bionanomatrix™. Learn more: endomimetics.com/about/

Launching later this year: our first spinout! Endomimetics® is now an IP Foundry, fast-tracking patient access to our proprietary Bionanomatrix™ technology through specialized companies. First focus: improving dialysis vascular access and outcomes for patients worldwide.

Arteriovenous Fistula (AVF) remains the standard access for dialysis but high failure rates continue to impact clinical outcomes. Bionanomatrix™ is designed to support maturation and improve longevity by reducing complications. Learn more >  endomimetics.com/technology/

Engineered to work with the body, its biomimetic design promotes healing, reduces inflammation, and supports tissue integration. Learn more about the science behind Bionanomatrix™ >>> endomimetics.com/technology/

Two ways to invest in the Endomimetics IP Foundry: • Platform access to the Bionanomatrix™ portfolio • Application-focused investments with clear milestones Learn more: endomimetics.com

Bionanomatrix™ mimics the body’s natural environment to reduce inflammation, inhibit clot formation, and support healthier healing. Learn more> endomimetics.com/technology/

Endomimetics® CEO, Dr. Joseph Garner, shares an overview of our proprietary Bionanomatrix™ technology and what we need to fuel our next phase of growth.

Just announced! We are excited to share that Endomimetics® has restructured into an IP Foundry business model. Read more about what this means for our pipeline. > accessnewswire.com/newsroom/…

Bionanomatrix™ is engineered for real clinical impact across vascular, cardiovascular, orthopedic, dental, and neuro applications—helping enhance healing and improve patient outcomes. Learn more: endomimetics.com/pipeline/

Bionanomatrix™ delivers nitric oxide directly to tissues, continuously and precisely. Learn more about the many applications of Bionanomatrix >>> endomimetics.com/technology/

Advancing the future of healing, from discovery to recovery. Meet the team behind our Bionanomatrix™ technology. >>> endomimetics.com/team/

Bionanomatrix™, our proprietary technology, is shaping the future of healing and recovery with potential applications across a variety of specialties. Follow and discover more about Bionanomatrix today > endomimetics.com/technology/

What if healing could happen differently? At Endomimetics®, our Bionanomatrix™ technology is paving the way. Follow to learn more and visit us at endomimetics.com/